BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Morita K, Namimoto T, Awai K, Komi M, Hashida M, Tsuji T, Hirai T, Yamashita Y. Enhancement effects of hepatic dynamic MR imaging at 3.0 T and 1.5 T using gadoxetic acid in a phantom study: comparison with gadopentetate dimeglumine: Enhancement Effects of Gadoxetic Acid. Magn Reson Med 2011;66:213-8. [DOI: 10.1002/mrm.22770] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Yu S, Paek M, Kim S, Ji Y, Goo E, Lee S, Park C, Choe B. Evaluation of Enhancement Effects as a Function of the Molarity of Gd-Based Contrast Media at 3.0 and 1.5 T: Based on the T1 Effective Pulse Sequence Parameter. Appl Magn Reson 2013;44:519-30. [DOI: 10.1007/s00723-012-0399-5] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Wibmer A, Prusa AM, Nolz R, Gruenberger T, Schindl M, Ba-Ssalamah A. Liver failure after major liver resection: risk assessment by using preoperative Gadoxetic acid-enhanced 3-T MR imaging. Radiology. 2013;269:777-786. [PMID: 23942606 DOI: 10.1148/radiol.13130210] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 5.9] [Reference Citation Analysis]
3 Fujinaga Y, Ueda H, Kitou Y, Tsukahara Y, Sugiyama Y, Kadoya M. Time-intensity curve in the abdominal aorta on dynamic contrast-enhanced MRI with high temporal and spatial resolution: Gd-EOB-DTPA versus Gd-DTPA in vivo. Jpn J Radiol 2013;31:166-71. [PMID: 23179788 DOI: 10.1007/s11604-012-0162-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
4 AlObaidy M, Ramalho M, Velloni F, Matos AP, Herman K, Semelka RC. Enhancement of abdominal structures on MRI at 1.5 and 3 T: a retrospective intraindividual crossover comparison. Eur Radiol 2017;27:1596-604. [PMID: 27436014 DOI: 10.1007/s00330-016-4494-0] [Reference Citation Analysis]
5 Lin Y, Hwang R, Chen B, Hsu C, Yu C, Kao J, Lee H, Liang P, Wei S, Shih TT. Vascular and hepatic enhancements at MR imaging: comparison of Gd-EOB-DTPA and Gd-DTPA in the same subjects. Clinical Imaging 2014;38:287-91. [DOI: 10.1016/j.clinimag.2014.01.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
6 Nakamura Y, Kimura T, Higaki T, Honda Y, Komoto D, Yamagami T, Iida M, Nagata Y, Honda Y, Aikata H, Chayama K, Awai K. Clinical utility of gadoxetate disodium-enhanced hepatic MRI for stereotactic body radiotherapy of hepatocellular carcinoma. Jpn J Radiol 2015;33:627-35. [PMID: 26227061 DOI: 10.1007/s11604-015-0465-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
7 Ramalho M, AlObaidy M, Busireddy KK, Altun E, Liu B, Semelka RC. Quantitative and qualitative comparison of 0.025 mmol/kg gadobenate dimeglumine for abdominal MRI at 1.5T and 3T MRI in patients with low estimated glomerular filtration rate. Eur J Radiol. 2015;84:26-32. [PMID: 25467229 DOI: 10.1016/j.ejrad.2014.10.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]